The Lancet. Oncology
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019..
23:27-52.
2021
-
Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial..
22:1721-1731.
2021
-
Immunotherapy in ovarian cancer: we are not there yet..
22:903-905.
2021
-
Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial..
22:632-642.
2021
-
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial..
22:620-631.
2021
-
The effect of non-AIDS-defining cancers on people living with HIV..
22:e240-e253.
2021
-
Fulvestrant plus capivasertib for metastatic breast cancer..
21:-.
2020
-
Trifluridine/tipiracil in metastatic gastric cancer..
20:-.
2019
-
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial..
18:1274-1284.
2017
-
Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial..
17:1579-1589.
2016
-
Recognition of surgical need as part of cancer control in Africa..
14:-.
2013
-
Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial..
14:749-59.
2013
-
Keynote comment: cancer survivorship and ageing--a double whammy..
7:882-3.
2006
Identity
International Standard Serial Number (ISSN)